Abstract
Targeting antigens to dendritic cells (DCs) by using hybrid monoclonal antibodies (mAbs) directed against DC receptors is known to improve activation and support long-lasting T cell responses. In the present work, we used the mAb αDEC205 fused to the Trypanosoma cruzi amastigote surface protein 2 (ASP-2) to identify a region of this protein recognized by specific T cells. The hybrid αDEC-ASP2 mAb was successfully generated and preserved its ability to bind the DEC205 receptor. Immunization of BALB/c mice with the recombinant mAb in the presence of polyriboinosinic: polyribocytidylic acid (poly (I:C)) specifically enhanced the number of IFN-γ producing cells and CD4+ T cell proliferation when compared to mice immunized with a mAb without receptor affinity or with the non-targeted ASP-2 protein. The strong immune response induced in mice immunized with the hybrid αDEC-ASP2 mAb allowed us to identify an ASP-2-specific CD4+ T cell epitope recognized by the BALB/c MHCII haplotype. We conclude that targeting parasite antigens to DCs is a useful strategy to enhance T cell mediated immune responses facilitating the identification of new T-cell epitopes.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Monoclonal / genetics
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / metabolism
-
Antibody Formation
-
Antigens, Protozoan / chemistry
-
Antigens, Protozoan / genetics
-
Antigens, Protozoan / immunology*
-
CD4-Positive T-Lymphocytes / immunology*
-
CD4-Positive T-Lymphocytes / metabolism
-
Chagas Disease / immunology
-
Chagas Disease / metabolism
-
Dendritic Cells / immunology*
-
Dendritic Cells / metabolism
-
Disease Models, Animal
-
Epitopes, T-Lymphocyte / immunology*
-
Female
-
HEK293 Cells
-
Humans
-
Immunization
-
Immunodominant Epitopes / immunology*
-
Mice
-
Neuraminidase / genetics
-
Neuraminidase / immunology
-
Peptides / immunology
-
Protein Binding / immunology
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / immunology
-
Recombinant Fusion Proteins / metabolism
-
Trypanosoma cruzi / immunology*
Substances
-
Antibodies, Monoclonal
-
Antigens, Protozoan
-
Epitopes, T-Lymphocyte
-
Immunodominant Epitopes
-
Peptides
-
Recombinant Fusion Proteins
-
ASP-2 protein, Trypanosoma cruzi
-
Neuraminidase
Grants and funding
This research was supported by the Brazilian National Research Council (CNPq)/National Institutes of Science and Technology in Vaccines (INCTV, 15203*12), Sao Paulo State Research Funding Agency (FAPESP, 2007/08648-9) and BNP-Paribas Bank. E.V. Rampazo, K.N.S. Amorim and R.H. Panatieri received fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge that partial funding for this study was provided by the commercial source BNP-Paribas Bank. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.